@OncEd Presents Dr. Normand Blais – Debate: Targeted Therapy VS. Immunotherapy For First Line In NSCLC – YES – CLCCO 2015 admin 9 years ago @OncEd Presents Dr. Normand Blais – Debate: Targeted Therapy VS. Immunotherapy For First Line In NSCLC – YES – CLCCO 2015
